T he main active ingredient or salt in Virso (400 mg) is Sofosbuvir.
Sofosbuvir (International brand name Sovaldi) is used along with ribavirin (Copegus, Rebetol) and sometimes another medication (peginterferon alfa - Pegasys) to treat chronic hepatitis C (an ongoing viral infection that damages the liver). Sofosbuvir is also used along with ribavirin (Copegus, Rebetol) in people with liver cancer and hepatitis C infection who are waiting for a liver transplant to treat hepatitis C infection and to decrease the risk of reinfection after the transplant. Sofosbuvir is in a class of antiviral medications called nucleotide polymerase inhibitors. It works by decreasing the amount of hepatitis C virus (HCV) in the body. Sofosbuvir may not prevent the spread of hepatitis C to other people. In comparison to hepatitis C virus treatment in the past, sofosbuvir-based regimens provide a higher cure rate, fewer side effects, and a 2-4 times reduced duration of therapy. Sofosbuvir allows most people to be treated successfully without the use of peginterferon, an injectable drug with severe side effects that is a key component of older drug combinations for the treatment of hepatitis C virus.
This is custom tab. You can add custom tab as an attribute for entire products, or for each categories. You can add CMS content such as sizing guide or videos to enhance product detail.